Long-Term Agreement Secures Dedicated Capacity for Multi-Ton Annual Supply of VK2735 Active Pharmaceutical Ingredient Secures Dedicated Fill/Finish Capacity for 100 Million Annual Autoinjector Supply ...
TAMPA, FL / ACCESS Newswire / June 2, 2025 / Pure Solutions Inc., a wholly owned subsidiary of Full Alliance Group, Inc. (FAGI), today announced a strategic manufacturing agreement with Stemtech ...
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
VALENCIA, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced ...
Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to ...
Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...
DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
SYDNEY, June 17, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that ...
SINGAPORE, June 25, 2025 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCPK: ALRTF), the diabetes management company, announces it has entered into a Definitive Manufacturing ...
Hosted on MSN
REPRO-MED Systems Signs New Manufacturing Agreement
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases Manufacturing agreement supports advancement of ...
The newly committed suite is the first of four manufacturing suites ProMed is constructing at Niagara Lane to support growing demand for manufacture of ophthalmic implants and other sustained-release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results